Navigation Links
International Hyaluronic Acid Viscosupplementation Physician Survey 2011
Date:7/5/2011

NEW YORK, July 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

International Hyaluronic Acid Viscosupplementation Physician Survey 2011

http://www.reportlinker.com/p0567542/International-Hyaluronic-Acid-Viscosupplementation-Physician-Survey-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

Over 100 orthopedic specialists were surveyed regarding their perceptions and usage of hyaluronic acid viscosupplementation during the 2011 American Academy of Orthopaedic Surgeons (AAOS) conference. This survey report compares usage patters and perceptions of orthopedic specialists regarding hyaluronic acid viscosupplement product, including single injection, 3-injection and 5-injection therapy regimes. Satisfaction with current offerings is examined in detail, along with the market penetration of single injection products. The data presented describes practice experience, practice volume and the attitudes of the respondents to the product, as well as how these factors interact. In addition to physician brand preference, this survey report describes the proportion of doctors who would be willing to switch to a single injection product like Genzyme's Synvisc-One®. The results of the survey indicated a high degree of familiarity with the product within the physician community. There is a general divide in the U.S. medical community between HA brands that are used for a majority of procedures within a practice. The respondents were asked to rate their satisfaction with the various injection products. This in term was compared to the probability of switching brands, and the possible motivating reasons for doing so.

The executive summary of this report is also available for purchase.

TABLE OF CONTENTS

TABLE OF CONTENTS .I

LIST OF FIGURES.IV

LIST OF CHARTS VII

EXECUTIVE SUMMARY 1

1.1 OVERVIEW .. 1

1.2 RESPONDENT PRACTICE LOCATION 2

1.3 COMPETING BRANDS . 3

1.4 PURCHASING CHANNELS . 4

1.5 IMPORTANCE OF PRICING 5

1.6 SATISFACTION WITH SINGLE INJECTION.. 6

1.7 PURCHASING DECISIONS.. 7

1.8 TIME TO PAIN RELIEF AFTER HA TREATMENT 8

SURVEY HIGHLIGHTS 9

2.1 RESPONDENT CHARACTERISTICS 9

2.1.1 Doctor Profile 9

2.1.2 Purchasing Channel 10

2.2 RESPONSE SUMMARY . 10

2.2.1 Attitudes Towards Products. 10

2.2.2 Product Incentives 10

2.2.3 Patient Profile. 11

2.2.4 Brand Preferences 11

RESEARCH METHODOLOGY 12

3.1 RESEARCH OVERVIEW 12

3.2 RESEARCH SERVICES .. 12

3.3 SURVEY METHODOLOGY.. 13

Step 1: Project Initiation & Team Selection 13

Step 2: Sample Population Preparation 15

Step 3: Preparation, Questionnaire Design & Administration.. 16

Step 4: Reporting and Analysis.. 18

Step 5: Customer Feedback . 18

HYALURONIC ACID VISCOSUPPLEMENTATION SURVEY RESULTS.. 19

4.1 QUESTION 1: YEARS OF PRACTICE .. 19

4.1.1 Practice Experience by Global Region.. 19

4.1.2 Country of Origin.. 21

4.2 QUESTION 2: HYALURONIC ACID (HA) VISCOSUPPLEMENT PATIENTS PER MONTH. 28

4.2.1 HA Patients per Month .. 28

4.2.2 Monthly HA Patients by Practice Experience. 30

4.3 QUESTION 3: HA UTILIZATION BY BRAND.. 32

4.4 QUESTION 4:REASONS FOR CHOOSING HA BRAND. 39

4.4.1 Reasons for Choosing Brand .. 39

4.4.2 Reasons for Choosing Brand by Brand Preference . 41

4.5 QUESTION 5: LIKELIHOOD OF INCREASING SINGLE INJECTION USE .. 48

4.6 QUESTION 6: SATISFACTION WITH SINGLE INJECTION PRODUCTS.. 50

4.6.1 Satisfaction with Single Injection.. 50

4.6.2 Likelihood of Increasing Single Injection Use by Satisfaction .. 52

4.7 QUESTION 7: PERCENTAGE OF HA PATIENTS THAT SUBSEQUENTLY GO ON TO TOTAL

KNEE ARTHROPLASTY (TKA) 57

4.8 QUESTION 8: TIME TO TKA AFTER HA AND CONSERVATIVE TREATMENTS. 59

4.8.1 Time to TKA. 59

4.8.2 Time to TKA by Surgical Volume.. 61

4.9 QUESTION 9: HA INJECTION TYPES USED BEFORE TKA.. 66

4.10 QUESTION 10: PERCEIVED BRAND PURCHASING INCENTIVES 70

4.11 QUESTION 11: NATURE OF INCENTIVES RECEIVED .. 72

4.12 QUESTION 12: REASONS TO SWITCH TO DIFFERENT HA BRAND.. 74

4.12.1 General Reasons to Switch Brands 74

4.12.2 Reasons to Switch Brands by Brand Attribute Preference. 76

4.13 QUESTION 13: PATIENT GROUPS RECEIVING THE MOST BENEFIT FROM HA.. 78

4.14 QUESTION 14: IMPORTANCE OF PRICING 80

4.15 QUESTION 15: NATURE OF PURCHASING CHANNELS .. 82

4.15.1 Purchasing Channels 82

4.15.2 Importance of Pricing by Purchasing Channel .. 84

4.16 QUESTION 16: RESPONDENT CLINICAL SETTING 86

4.17 QUESTION 17 TO 18: TIME TO RELIEF AFTER TREATMENT .. 88

4.17.1 Question 17: Time to Relief After Single Injection Treatment. 88

4.17.2 Question 18: Time to Relief After 3-Injection Treatment 89

4.17.3 Question 19: Time to Relief After 5-Injection Treatment 90

APPENDIX 1: SURVEY QUESTIONS.. 91

LIST OF FIGURES

EXECUTIVE SUMMARY. 1

SURVEY HIGHLIGHTS 9

RESEARCH METHODOLOGY 12

HYALURONIC ACID VISCOSUPPLEMENTATION SURVEY RESULTS . 19

Figure 4-1: Years of Practice, 2011. 19

Figure 4-2: Country of Origin, Asia, 2011 21

Figure 4-3: Country of Origin, Europe, 2011.. 21

Figure 4-4: Country of Origin, Latin America, 2011 22

Figure 4-5: Country of Origin, Africa, Middle East and Caribbean, 2011 .. 22

Figure 4-6: HA Patients Treated per Month, 2011 28

Figure 4-7: Monthly HA Patients Seen by Years of Practice, 2011 30

Figure 4-8: Weighted Average for HA Brand Frequency of Use, Asia, 2011 32

Figure 4-9: Weighted Average for HA Brand Frequency of Use, Europe, 2011 .. 33

Figure 4-10: Weighted Average for HA Brand Frequency of Use, Latin America,

2011 34

Figure 4-11: Weighted Average for HA Brand Frequency of Use, Other, 2011 34

Figure 4-12: Reasons for Choosing a HA Brand, 2011 39

Figure 4-13: Reasons for Choosing Brand by Brand Choice, Asia, 2011 41

Figure 4-14: Reasons for Choosing Brand by Brand Choice, Europe, 2011 .. 42

Figure 4-15: Reasons for Choosing Brand by Brand Choice, Latin America, 2011. 42

Figure 4-16: Reasons for Choosing Brand by Brand Choice, Middle East, Africa and

Caribbean . 43

Figure 4-17: Likelihood of Switching to Single Injection, 2011 . 48

Figure 4-18: Satisfaction with Single Injection Products, 2011 .. 50

Figure 4-19: Likelihood of Increasing Single Injection Usage as a Function of Single

Injection Satisfaction, 2011.. 52

Figure 4-20: Percentage of HA Patients that Subsequently Go on to Total Knee

Arthroplasty (TKA), 2011 . 57

Figure 4-21: Time to TKA After HA and Conservative Treatments, Months, 2011 59

Figure 4-22: Time to TKA in Months per Percentage of Patients that Require TKA,

2011 61

Figure 4-23: HA Injection Types Used Before TKA, Weighted Average, 2011 66

Figure 4-24: HA Injection Types Used Before TKA by Response Distribution, Asia 66

Figure 4-25: HA Injection Types Used Before TKA by Response Distribution, Europe,

2011 67

Figure 4-26: HA Injection Types Used Before TKA by Response Distribution,

Latin America, 2011 67

Figure 4-27: HA Injection Types Used Before TKA by Response Distribution, Other,

2011 68

Figure 4-28: Perceived Brand Purchasing Incentives, 2011.. 70

Figure 4-29: Nature of Incentives Received, 2011 72

Figure 4-30: Reasons to Switch to Different HA Brand, 2011 . 74

Figure 4-31: Nature of Incentives Received by Brand Selection Preferences, Asia,

2011 76

Figure 4-32: Nature of Incentives Received by Brand Selection Preferences, Europe,

2011 76

Figure 4-33: Nature of Incentives Received by Brand Selection Preferences,

Latin America, 2011 77

Figure 4-34: Nature of Incentives Received by Brand Selection Preferences,

Middle East, Africa and Caribbean, 2011 .. 77

Figure 4-35: Patient Groups Receiving the Most Benefit from HA, 2011 .. 78

Figure 4-36: Importance of Pricing, 2011. 80

Figure 4-37: Purchasing Channels, 2011 .. 82

Figure 4-38: Importance of Pricing by Purchasing Channel, Asia, 2011 . 84

Figure 4-39: Importance of Pricing by Purchasing Channel, Europe, 2011 84

Figure 4-40: Importance of Pricing by Purchasing Channel, Latin America, 2011 . 85

Figure 4-41: Importance of Pricing by Purchasing Channel, Middle East Africa and

Caribbean, 2011. 85

Figure 4-42: Respondent Clinical Setting, 2011 86

Figure 4-43: Time to Relief After Single Injection Treatment, Weeks, 2011 88

Figure 4-44: Time to Relief After 3-Injection Treatment, Weeks, 2011 .. 89

Figure 4-45: Time to Relief After 5-Injection Treatment, Weeks, 2011 .. 90

APPENDIX 1: SURVEY QUESTIONS . 91

LIST OF CHARTS

EXECUTIVE SUMMARY. 1

Chart 1-1: Hyaluronic Acid Usage Among Survey Respondents, Latin America, 2011 .. 1

Chart 1-2: Respondent Location by Region, 2011 2

Chart 1-3: Brand Preference Among, Africa, Middle East and Caribbean, 2011 3

Chart 1-4: Purchasing Channels, Global, 2011 . 4

Chart 1-5: Perceived Importance of Pricing, Global, 2011 .. 5

Chart 1-6: Likelihood of Increasing Single Injection Use as a function of Satisfaction

Rating, Asia, 2011 .. 6

Chart 1-7: Reasons for Choosing a HA Brand, Europe, 2011 . 7

Chart 1-8: Time to Pain Relief in Weeks, 3-Injection Therapy, 2011 . 8

SURVEY HIGHLIGHTS 9

RESEARCH METHODOLOGY 12

HYALURONIC ACID VISCOSUPPLEMENTATION SURVEY RESULTS . 19

Chart 4-1: Years of Practice, 2011 .. 20

Chart 4-2: Respondents by Global Region, 2011 .. 23

Chart 4-3: Country of Origin, Asia, 2011 . 24

Chart 4-4: Country of Origin, Europe, 2011 25

Chart 4-5: Country of Origin, Latin America, 2011 . 26

Chart 4-6: Country of Origin, Africa, Middle East and Caribbean, 2011 27

Chart 4-7: HA Patients per Month, 2011 .. 29

Chart 4-8: Monthly HA Patients Seen by Years of Practice, 2011 . 31

Chart 4-9: Weighted Average for HA Brand Frequency of Use, Asia, 2011 .. 35

Chart 4-10: Weighted Average for HA Brand Frequency of Use, Europe, 2011 .. 36

Chart 4-11: Weighted Average for HA Brand Frequency of Use, Latin America,

2011 37

Chart 4-12: Weighted Average for HA Brand Frequency of Use, Other, 2011 . 38

Chart 4-13: Reasons for Choosing a HA Brand, 2011 . 40

Chart 4-14: Reasons for Choosing Brand by Brand Choice, Asia, 2011 .. 44

Chart 4-15: Reasons for Choosing Brand by Brand Choice, Europe, 2011 . 45

Chart 4-16: Reasons for Choosing Brand by Brand Choice, Latin America, 2011 .. 46

Chart 4-17: Reasons for Choosing Brand by Brand Choice, Middle East, Africa and

Caribbean . 47

Chart 4-18: Likelihood of Switching to Single Injection, 2011 .. 49

Chart 4-19: Satisfaction with Single Injection Products . 51

Chart 4-20: Likelihood of Increasing Single Injection Usage as a Function of Single

Injection Satisfaction, 2011.. 53

Chart 4-21: Likelihood of Increasing Single Injection Usage as a Function of Single

Injection Satisfaction, 2011.. 54

Chart 4-22: Likelihood of Increasing Single Injection Usage as a Function of Single

Injection Satisfaction, 2011.. 55

Chart 4-23: Likelihood of Increasing Single Injection Usage as a Function of Single

Injection Satisfaction, 2011.. 56

Chart 4-24: Percentage of HA Patients that Subsequently Go on to Total Knee

Arthroplasty (TKA), 2011 . 58

Chart 4-25: Time to TKA After HA and Conservative Treatments, 2011 60

Chart 4-26: Time to TKA in Months per Percentage of Patients that Require TKA,

Asia, 2011 62

Chart 4-27: Time to TKA in Months per Percentage of Patients that Require TKA,

Europe, 2011 .. 63

Chart 4-28: Time to TKA in Months per Percentage of Patients that Require TKA,

Latin America, 2011 64

Chart 4-29: Time to TKA in Months per Percentage of Patients that Require TKA,

Africa, Middle East and Caribbean, 2011 .. 65

Chart 4-30: HA Injection Types Used Before TKA, Weighted Average, 2011 . 69

Chart 4-31: Perceived Brand Purchasing Incentives, 2011 71

Chart 4-32: Nature of Incentives Received, 2011 . 73

Chart 4-33: Reasons to Switch to Different HA Brand, 2011 .. 75

Chart 4-34: Patient Groups Receiving the Most Benefit from HA, 2011 . 79

Chart 4-35: Importance of Pricing, 2011 .. 81

Chart 4-36: Purchasing Channels, 2011. 83

Chart 4-37: Respondent Clinical Setting, 2011 .. 87

APPENDIX 1: SURVEY QUESTIONS . 91

To order this report:

Orthopedic Industry: International Hyaluronic Acid Viscosupplementation Physician Survey 2011

Orthopedic Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EHE International Showcases The National Tourette Syndrome Association, Inc. with Month-Long Window Display in Rockefeller Center Plaza
2. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
3. Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease
4. Golden Meditech Acquires Shanghai East International Medical Centre
5. Pepto-Bismol and Nick Cannon Heat Things up at this Years Nathans Famous Fourth of July International Hot Dog Eating Contest
6. OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors
7. Cellular Dynamics International Unlocks the Potential of Banked Blood Samples
8. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
9. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
10. Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention
11. Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... Mass. and SAN CLEMENTE, Calif. , ... California -based mobile pulmonary function testing company, is now able ... PFT devices developed by ndd Medical Technologies , Inc. ... testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® ... , can get any needed testing done in the comfort ...
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):